BlackRock Japan’s Kite Pharma, Inc. KITE Stock Holding History

BlackRock Japan’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$17K	Sell	373 -10	-3%	-$491	﹤0.01%	1161
2016 Q3	$21K	Sell	383 -16	-4%	-$891	﹤0.01%	1118
2016 Q2	$20K	Buy	399 +56	+16%	+$2.75K	﹤0.01%	1169
2016 Q1	$16K	Sell	343 -60	-15%	-$2.91K	﹤0.01%	1218
2015 Q4	$25K	Sell	403 -7,308	-95%	-$514K	﹤0.01%	1138
2015 Q3	$429K	Sell	7,711 -53,069	-87%	-$3.34M	﹤0.01%	736
2015 Q2	$3.71M	Buy	60,780 +26,873	+79%	+$1.53M	0.01%	670
2015 Q1	$1.96M	Buy	33,907 +33,481	+7,859%	+$2.24M	0.01%	696
2014 Q4	$25K	Buy	+426	New	+$17.9K	﹤0.01%	1197

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

BlackRock Japan's KITE Position: Q4 2016 in Review

BlackRock Japan reduced its Kite Pharma, Inc. (KITE) stake by 2.6% in Q4 2016, selling an estimated $491 and leaving 373 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #1161.

BlackRock Japan first reported a position in KITE in Q4 2014 and has held it in 9 quarters since. The position peaked at $3.71M in Q2 2015. 184 funds tracked by Wall St. Rank hold KITE as of Q4 2016.

BlackRock Japan held 373 shares of Kite Pharma, Inc. worth $17K as of Q4 2016.
BlackRock Japan sold 10 Kite Pharma, Inc. shares in Q4 2016, an estimated $491.
Kite Pharma, Inc. made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1161 holding.
BlackRock Japan first reported a position in Kite Pharma, Inc. in Q4 2014 and has held it in 9 quarters since.
BlackRock Japan's Kite Pharma, Inc. position peaked at $3.71M in Q2 2015.
184 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.